Autocrine Role of Transforming Growth Factor

Levine, Alan E.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA049127-07
• Application #: 2093182
• Study Section: Metabolic Pathology Study Section (MEP)
• Project Start: 1988-12-01
• Project End: 1997-09-29
• Budget Start: 1994-09-30
• Budget End: 1997-09-29
• Support Year: 7
• Fiscal Year: 1994

Institution

• Name: University of Texas Health Science Center Houston
• Department: Biochemistry
• Type: Schools of Dentistry
• City: Houston
• State: TX
• Country: United States
• Zip Code: 77225

Publications

Maruvada, P; Levine, A E (1999) Increased transforming growth factor-alpha levels in human colon carcinoma cell lines over-expressing protein kinase C. Int J Cancer 80:72-7

Ramesh, G; Levine, A E (1995) Pro-transforming growth factor-alpha processing in human colon carcinoma cells: role of protein kinase C. Int J Cancer 62:492-7

Levine, A E (1994) Involvement of protein kinase C and an elastase-like enzyme in the processing of transforming growth factor-alpha in human colon carcinoma cell lines. Int J Cancer 58:129-34

Levine, A E; Lewis, L R (1993) Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line. Cancer Lett 68:33-41

Levine, A E; Chakrabarty, S (1992) Response of FR3T3 cells transformed by Ha-ras oncogene and epidermal growth factor gene to differentiation induction by N,N-dimethylformamide. Int J Cancer 50:653-8

Watkins, L F; Levine, A E (1991) Differential role of transforming growth factor-alpha in two human colon-carcinoma cell lines. Int J Cancer 47:455-60